Physician profile
Amanda T Larson
NPI 1508026444
$1,003.34
in general payments reported to CMS, 2019-2025
11 companies · $397 in 2025
The $397 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2024: $434 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $314.59 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Organogenesis INC. | $264.96 | 2024-2025 | Apligraf |
| Intuitive Surgical, INC. | $158.38 | 2019 | |
| Smith+Nephew, INC. | $119.33 | 2024-2025 | Pico, Collagenase Santyl, Renasys Touch |
| Mimedx Group, INC. | $29.35 | 2025 | |
| Advanced Oxygen Therapy INC. | $24.66 | 2025 | Topical Oxygen Chamber For Extremities |
| Ovik Health, LLC | $24.15 | 2024 | Coflex Tlc |
| Abbvie INC. | $19.83 | 2024 | |
| Hartmann USA, INC. | $18.13 | 2025 | Zetuvit Plus 10x10 P10 |
| Hydrofera LLC | $15.85 | 2024 | Hydrofera Blue Classic |
| Lemaitre Vascular, INC. | $14.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.